Century Therapeutics (NASDAQ: IPSC) is a biotechnology company advancing a pipeline of induced pluripotent stem cell (iPSC)-derived cell therapies with the potential to meaningfully address autoimmune diseases, including type 1 diabetes, and cancer. The company’s therapies are derived from its iPSC cell foundry and leverage its novel immune evasion engineering technology, Allo-Evasion™. Century believes its approach to developing off-the-shelf cell therapies will expand patient access and provide advantages over existing cell therapies which will ultimately advance the course of care. Role: Century Therapeutics is seeking a highly motivated Associate Scientist or Scientist to join the Islet Differentiation team group, focused on upstream process development for iPSC-derived pancreatic islet differentiation within the CNTY-813 program. This process-engineering focused role partners closely with existing research and process development leadership to develop, optimize, and scale bioreactor-based beta islet differentiation. The ideal candidate brings a strong process mindset, hands-on experience with bioreactors for stem cell differentiation, and a passion for translating biology into scalable, manufacturable systems. The successful candidate will contribute to experimental design using Quality by Design (QbD) principles, apply Design of Experiments (DOE), and help establish robust, reproducible processes for generating high-quality islet cell populations.?
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level